Skip Navigation
Jeffrey Holzbeierlein, MD, has been named physician-in-chief of The University of Kansas Cancer Center. Dr. Holzbeierlein is the William L. Valk endowed professor and chair of the Department of Urology at the University of Kansas Medical Center. He specializes in urologic cancer surgery, especially bladder, kidney, penile and testicular cancer. His research interests include Hsp90 inhibitors in bladder cancer and improving cystectomy (bladder removal) outcomes. He is also president of the Society of Urologic Oncology.

We are delighted to welcome Dr. Holzbeierlein to the role of physician in chief. He is an outstanding nationally recognized clinician, researcher and administrator, who will play a critical role in the continued growth and development of our clinical oncology program. His vast experience and direct knowledge of our program will play an essential role as we plan and develop new clinical facilities to fulfill our vision to become a destination cancer center. Roy Jensen, MD

Vice Chancellor and Director of KU Cancer Center

Learn More

Click here to learn more about Dr. Holzbeierlein.

Related links